title: Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells.
abstract: We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.
authors.affiliation: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; National Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
authors.forename: Zhenzhen
authors.initials: Z
authors.lastname: Hui
authors.affiliation: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; National Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
authors.forename: Xinwei
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; National Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
authors.forename: Baozhu
authors.initials: B
authors.lastname: Ren
authors.affiliation: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; National Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
authors.forename: Runmei
authors.initials: R
authors.lastname: Li
authors.affiliation: Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; National Clinical Research Center for Cancer, Tianjin, China; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China; Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
authors.forename: Xiubao
authors.initials: X
authors.lastname: Ren
keywords: cytokine-induced killer cells; immunotherapy; non-small cell lung cancer; pembrolizumab; thrombocytopenia